Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,823
Closed -$215K 224
2026
Q1
$215K Hold
1,823
0.08% 189
2025
Q4
$229K Sell
1,823
-600
-25% -$78.3K 0.08% 172
2025
Q3
$355K Hold
2,423
0.11% 154
2025
Q2
$378K Hold
2,423
0.13% 139
2025
Q1
$399K Buy
2,423
+900
+59% +$150K 0.17% 120
2024
Q4
$248K Buy
1,523
+323
+27% +$57.8K 0.16% 125
2024
Q3
$234K Buy
1,200
+100
+9% +$18.4K 0.11% 122
2024
Q2
$191K Hold
1,100
0.09% 138
2024
Q1
$186K Hold
1,100
0.09% 143
2023
Q4
$217K Hold
1,100
0.12% 109
2023
Q3
$191K Hold
1,100
0.11% 114
2023
Q2
$189K Hold
1,100
0.11% 110
2023
Q1
$183K Hold
1,100
0.11% 110
2022
Q4
$161K Hold
1,100
0.1% 125
2022
Q3
$163K Buy
+1,100
New +$184K 0.1% 106

Other funds holding ZTS

Alta Advisers's ZTS Position: Q2 2026 in Review

Alta Advisers sold out of Zoetis (ZTS) in Q2 2026, closing a stake of 1,823 shares — an estimated $215K sold.

Alta Advisers first reported a position in ZTS in Q3 2022 and held it in 15 quarters. The position peaked at $399K in Q1 2025. 1,429 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Alta Advisers reported no remaining Zoetis position as of Q2 2026 after selling out during the quarter.
  • Alta Advisers sold 1,823 Zoetis shares in Q2 2026, an estimated $215K.
  • Alta Advisers first reported a position in Zoetis in Q3 2022 and held it in 15 quarters.
  • Alta Advisers's Zoetis position peaked at $399K in Q1 2025.
  • 1,429 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Alta Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.